Order Article Reprints

Botta C, Agostino RM, Dattola V, Cianci V, Calandruccio ND, Bianco G, Mafodda A, Maisano R, Iuliano E, Orizzonte G, et al. Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report. International Journal of Molecular Sciences. 2021; 22(12):6246. https://doi.org/10.3390/ijms22126246

Botta, Cirino, Rita Maria Agostino, Vincenzo Dattola, Vittoria Cianci, Natale Daniele Calandruccio, Giovanna Bianco, Antonino Mafodda, Roberto Maisano, Eleonora Iuliano, Giovanna Orizzonte, and et al. 2021. "Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report" International Journal of Molecular Sciences 22, no. 12: 6246. https://doi.org/10.3390/ijms22126246

Botta, C., Agostino, R. M., Dattola, V., Cianci, V., Calandruccio, N. D., Bianco, G., Mafodda, A., Maisano, R., Iuliano, E., Orizzonte, G., Mazzacuva, D., Falzea, A. C., Saladino, R. E., Giannicola, R., Restifo, G., Aguglia, U., Caraglia, M., & Correale, P. (2021). Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report. International Journal of Molecular Sciences, 22(12), 6246. https://doi.org/10.3390/ijms22126246